Aversion to ambiguity regarding medical tests and treatments: measurement, prevalence, and relationship to sociodemographic factors

Paul K J Han, Bryce B Reeve, Richard P Moser, William M P Klein, Paul K J Han, Bryce B Reeve, Richard P Moser, William M P Klein

Abstract

Aversion to "ambiguity"-uncertainty about the reliability, credibility, or adequacy of risk-related information-is an important problem that may influence judgments and decisions about medical interventions. Ambiguity aversion (AA) varies among individuals, however, and has been understudied in the health domain. To explore this phenomenon further, we developed a new theory-based measure of aversion to ambiguity regarding medical tests and treatments, and examined the prevalence and association of AA with sociodemographic factors. The "AA-Med" scale was developed using a large survey sample of the U.S. public (n = 4,398), and scale psychometric properties and the population distribution of AA were evaluated. The scale demonstrated acceptable reliability (alpha = .73) and validity as ascertained by association with respondents' interest in a hypothetical ambiguous cancer screening test. Ambiguity aversion (AA) was associated with older age, non-White race, lower education and income, and female sex. The AA-Med scale is a promising new measure, and AA is associated with several sociodemographic factors. We discuss implications of these findings and potential applications of the scale for future research.

References

    1. Armstrong K, Weiner J, Weber B, Asch DA. Early adoption of BRCA1/2 testing: Who and why. Genetics in Medicine. 2003;5(2):92–98.
    1. Briss P, Rimer B, Reilley B, Coates RC, Lee NC, Mullen P, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. American Journal of Preventive Medicine. 2004;26(1):67–80.
    1. Brouwers MC, Sorrentino RM. Uncertainty orientation and protection motivation theory: The role of individual differences in health compliance. Journal of Personality and Social Psychology. 1993;65(1):102–112.
    1. Budner S. Intolerance of ambiguity as a personality variable. Journal of Personality. 1962;30:29–59.
    1. Buhr K, Dugas M. Intolerance for uncertainty scale: Psychometric properties of the English version. Behaviour Research and Therapy. 2002;40:931–946.
    1. Camerer C, Weber M. Recent developments in modeling preferences Uncertainty and ambiguity. Journal of Risk and Uncertainty. 1992;5:325–370.
    1. Carney PA, Elmore JG, Abraham LA, Gerrity MS, Hendrick RE, Taplin SH, et al. Radiologist uncertainty and the interpretation of screening. Medical Decision Making. 2004;24(3):255–264.
    1. Curley SP, Yates JF. An empirical evaluation of descriptive models of ambiguity reactions in choice situations. Journal of Mathematical Psychology. 1989;33:397–427.
    1. Einhorn HJ, Hogarth RM. Decision making under ambiguity. Journal of Business. 1986;59(4):S225–S250.
    1. Ellsberg D. Risk, ambiguity, and the Savage axioms. Quarterly Journal of Economics. 1961;75:643–669.
    1. Fridinger F, Macera C, Cordell HK. The use of surveillance data and market research to promote physical activity. American Journal of Preventive Medicine. 2002;23(Suppl 2):56–63.
    1. Furnham A, Ribchester T. Tolerance of ambiguity: A review of the concept, its measurement and applications. Current Psychology. 1995;14(3):179–199.
    1. Geller G, Tambor ES, Chase GA, Holtzman NA. Measuring physicians’ tolerance for ambiguity and its relationship to their reported practices regarding genetic testing. Medical Care. 1993;31(11):989–1001.
    1. Gerrity MS, DeVellis RF, Earp JA. Physicians’ reactions to uncertainty in patient care. A new measure and new insights. Medical Care. 1990;28(8):724–736.
    1. Goldsmith RE, Goldsmith EB. An empirical study of overlap of innovativeness. Psychological Reports. 1996;79:1113–1114.
    1. Goldsmith RE, Hofacker CF. Measuring consumer innovativeness. Journal of the Academy of Marketing Science. 1991;19:209–221.
    1. Greco V, Roger D. Coping with uncertainty: The construction and validation of a new measure. Personality and Individual Differences. 2001;31:519–534.
    1. Groeneveld PW, Sonnad SS, Lee AK, Asch DA, Shea JE. Racial differences in attitudes toward innovative medical technology. Journal of General Internal Medicine. 2006;21:559–563.
    1. Gust DA, Kennedy A, Shui I, Smith PJ, Nowak G, Pickering LK. Parent attitudes toward immunizations and healthcare providers the role of information. American Journal of Preventive Medicine. 2005;29(2):105–112.
    1. Han PK, Moser RP, Klein WM. Perceived ambiguity about cancer prevention recommendations: Relationship to perceptions of cancer preventability, risk, and worry. Journal of Health Communication. 2006;11(Suppl 1):51–69.
    1. Han PK, Moser RP, Klein WM. Perceived ambiguity about cancer prevention recommendations: Associations with cancer-related perceptions and behaviours in a US population survey. Health Expectations. 2007;10(4):321–336.
    1. Han PKJ, Kobrin SC, Klein WMP, Davis WW, Stefanek ME, Taplin SH. Perceived ambiguity about screening mammography recommendations: Association with future mammography uptake and perceptions. Cancer Epidemiology, Biomarkers, and Prevention. 2007;16(3):458–456.
    1. Han PKJ, Moser RP, Klein WMP, Beckjord EB, Dunlavy AC, Hesse BW. Predictors of perceived ambiguity about cancer prevention recommendations: Sociodemographic factors and mass media exposures. Health Communication (in press)
    1. Jepson RG, Forbes CA, Sowden AJ, Lewis RA. Increasing informed uptake and non-uptake of screening: Evidence from a systematic review. Health Expectations. 2001;4(2):116–126.
    1. Kahn BE, Sarin RK. Modeling ambiguity in decisions under uncertainty. Journal of Consumer Research. 1988;15(2):265–272.
    1. Kreuter MW, Holt CL, Skinner CS. Awareness of mammography controversy among lower-income African American women in urban public health centers. Journal of Womens Health (Larchmt) 2004;13(1):121–122.
    1. Kruglanski AW, Webster DM. Motivated closing of the mind: “Seizing” and “freezing”. Psychological Review. 1996;103(2):263–283.
    1. Kuhn KM. Communicating uncertainty: Framing effects on responses to vague probabilities. Organizational Behavior and Human Decision Process. 1997;71(1):55–83.
    1. Kuhn KM, Budescu DV. The relative importance of probabilities, outcomes, and vagueness in hazard risk decisions. Organizational Behavior and Human Decision Process. 1996;68(3):301–317.
    1. Maibach EW, Maxfield A, Ladin K, Slater M. Translating health psychology into effective health communication: The American Healthstyles audience segmentation project. Journal of Health Psychology. 1996;1(3):261–277.
    1. Maibach EW, Weber D, Massett H, Hancock GR, Price S. Understanding consumers’ health information preferences: Development and validation of a brief screening instrument. Journal of Health Communication. 2006;11(8):717–736.
    1. Meszaros JR, Asch DA, Baron J, Hershey JC, Kunreuther H, Schwartz-Buzaglo J. Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. Journal of Clinical Epidemiology. 1996;49(6):697–703.
    1. Miller SM. Monitoring and blunting: Validation of a questionnaire to assess styles of information seeking under threat. Journal of Personality and Social Psychology. 1987;52(2):345–353.
    1. Mishel MH. The measurement of uncertainty in illness. Nursing Research. 1981;30(5):258–263.
    1. Mishel MH. Adjusting the fit: Development of uncertainty scales for specific clinical populations. Western Journal of Nursing Research. 1983;5(4):355–370.
    1. Nelson DE, Gallogly M, Pederson LL, Barry M, McGoldrick D, Maibach EW. Use of consumer survey data to target cessation messages to smokers through mass media. American Journal of Public Health. 2008;98(3):536–542.
    1. O’Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, et al. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. American Journal of Medical Genetics, Part C, Seminars in Medical Genetics. 2006;142C(4):251–259.
    1. Politi MC, Han PK, Col NF. Communicating the uncertainty of harms and benefits of medical interventions. Medical Decision Making. 2007;27(5):681–695.
    1. Pollard WE. Use of consumer panel survey data for public health communication planning: An evaluation of survey results. Annual Meeting of the American Statistical Association, Joint Statistical Meetings; New York, NY. 2002.
    1. Porter-Novelli ConsumerStyles and HealthStyles 2007. Internal communication. 2008.
    1. Raffle A. Information about screening––is it to achieve high uptake or to ensure informed choice? Health Expectations. 2001;4(2):92–98.
    1. Ritov I, Baron J. Reluctance to vaccinate: Omission bias and ambiguity. Journal of Behavioral Decision Making. 1990;3:263–277.
    1. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research. 2002;11:193–205.
    1. Smithson M. Conflict aversion: Preference for ambiguity vs conflict in sources and evidence. Organizational Behavior and Human Decision Process. 1999;79(3):179–198.
    1. Sorrentino RM, Roney CJR. The uncertain mind: Individual differences in facing the unknown. Philadelphia: Taylor & Francis; 2000.
    1. Viscusi WK, Magat WA, Huber J. Smoking status and public responses to ambiguous scientific risk evidence. Southern Economic Journal. 1999;66(2):250–270.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever